Ventyx Biosciences, Inc. (VTYX)

NASDAQ | Biotech | Biotechnology and drug development
Intro rate Introductory pricing for early customers through June 30 — the same full analysis at a lower rate while we refine delivery.
Free
No email, no account, no signup.
Pulling latest news for Ventyx Biosciences, Inc.…
Bull
Bear
Intro rate Introductory pricing for early customers through June 30 — the same full analysis at a lower rate while we refine delivery.

Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.

Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99 $1.25.
Get the deep 4-model report – $4.99 $1.25
Order analysis – $4.99 $1.25

Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.

Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology and drug development
Market Cap
$1.0B
We're already tracking Ventyx Biosciences, Inc. — here are the latest events we've registered

Recent News

  • On March 4, 2026, Ventyx Biosciences was acquired by Eli Lilly and Company in an all-cash transaction valued at approximately $1.2 billion, or $14.00 per share. Following the completion of the merger, the company became a wholly owned subsidiary of Eli Lilly and its common stock was delisted from the Nasdaq.
Want to know how this news affects Ventyx Biosciences, Inc.? Order the analysis.
Order analysis – $4.99 $1.25

What you get

A complete express analysis — not just a signal. Delivered as a webpage in your account.

  • Signal: BUY / HOLD / SELL — with clear reasoning
  • Sentiment score 1–10 based on news, reports, and market data
  • Risk score 1–10 (dilution, jurisdiction, execution)
  • Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
  • Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
  • Upcoming catalysts with dates
  • Sources: news, filings, market data, and investor forums
  • Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Ventyx Biosciences, Inc. will be delivered in the same format.
Order analysis – $4.99 $1.25
Not satisfied? Get your money back within 7 days — no questions asked.
Ventyx Biosciences, Inc. (VTYX)
Fresh analysis on demand
Buy express analysis – $4.99 $1.25
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.